In 2023, the biotechnology R&D intensity in the business sector in Italy stood at 3.82% of BERD. From 2024 to 2028, the forecasted figures indicate a steady rise in R&D intensity, with values increasing incrementally from 3.85% in 2024 to 3.97% in 2028. This reflects a year-on-year growth ranging from approximately 1.04% to 0.51% in the latter years. Over the last five years, the Compound Annual Growth Rate (CAGR) is projected to be 0.99%.

Future trends to watch for include:

Increased investment in emerging biotechnology fields such as genetic engineering and synthetic biology.
Government policies and incentives aimed at boosting R&D initiatives in the biotech sector.
Collaborations between Italian biotech firms and international partners to leverage advanced technologies.